Independent and opposite associations of trunk and leg fat depots with adipokines, inflammatory markers, and metabolic syndrome in middle-aged and older Chinese men and women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4389-4398

  Wu, Hongyu ^a   Qi, Qibin ^a   Yu, Zhijie ^a   Sun, Qi ^b   Wang, Jing ^a   Franco, Oscar H ^c,d   Sun, Liang ^a   Li, Huaixing ^a   Liu, Yong ^a   Hu, Frank B ^b   Lin, Xu ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RETINOL BINDING PROTEIN 4; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; BODY FAT; BODY SIZE; DISEASE ASSOCIATION; FEMALE; HUMAN; LEG; LIPID STORAGE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SEX DIFFERENCE; TRUNK; ABDOMEN; ADIPOSE TISSUE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BODY FAT DISTRIBUTION; COMPLICATION; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY; STATISTICS; STATISTICS AND NUMERICAL DATA; THORAX;

ABDOMEN; ADIPOKINES; ADIPOSE TISSUE; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEG; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; STATISTICS AS TOPIC; THORAX;

EID: 77956568098     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0181     Document Type: Article

References (39)

1. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB 2008 Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117:1658-1667
2. Boorsma W, Snijder MB, Nijpels G, Guidone C, Favuzzi AMR, Mingrone G, Kostense PJ, Heine RJ, Dekker JM 2008 Body composition, insulin sensitivity, and cardiovascular disease profile in healthy europeans. Obesity 16:2696-2701
3. Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, Johnson A, Cronin J, Steinberg HO, Baron AD 1999 Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 22:1310-1317
4. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM 2002 Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 282:E1023-E1028
5. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC 2004 Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 27:372-377
6. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM 2005 Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 90:4573-4578
7. Sakai Y, Ito H, Egami Y, Ohoto N, Hijii C, Yanagawa M, Satoh S, Jingu S 2005 Favourable association of leg fat with cardiovascular risk factors. J Intern Med 257:194-200
8. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, Treuth MS 1997 Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr 65:855-860
9. Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C 2003 Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107:1626-1631
10. Godsland IF, Crook D, Proudler AJ, Stevenson JC 2005 Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome. J Clin Endocrinol Metab 90:190-197
11. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB 2009 Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129-2140
12. Rosen ED, Spiegelman BM 2006 Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847-853
13. Tankó LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C, Larsen PJ 2004 Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 110:2246-2252
14. Buemann B, Astrup A, Pedersen O, Black E, Holst C, Toubro S, Echwald S, Holst JJ, Rasmussen C, Sørensen TI 2006 Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. J Clin Endocrinol Metab 91:1698-1704
15. Snijder MB, Flyvbjerg A, Stehouwer CD, Frystyk J, Henry RM, Seidell JC, Heine RJ, Dekker JM 2009 Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur J Endocrinol 160:387-395
16. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X 2007 Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49:1798-1805
17. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, Franco OH, Wang J, Li H, Liu Y, Lin X 2007 Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92:4827-4834
18. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X 2007 Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity 16:172-178
19. Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X 2008 Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol 159:585-593
20. Ye X, Franco OH, Yu Z, Li H, Hu FB, Liu H, Wang X, Tang H, Liu Y, Chen Y, Lin X 2009 Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people. Clin Endocrinol (Oxf) 70:854-862
21. Cole TJ, Fewtrell MS, Prentice A 2008 The fallacy of using percentage body fat as a measure of adiposity. Am J Clin Nutr 87:1959; author reply 1959-1960.
22. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL 2007 Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86:353-359
23. Silha JV, Nyomba BL, Leslie WD, Murphy LJ 2007 Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care 30:286-291
24. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T 2009 Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 32:932-937
25. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA 2007 Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 92:1886-1890
26. Gavi S, Qurashi S, Stuart LM, Lau R, Melendez MM, Mynarcik DC, McNurlan MA, Gelato MC 2008 Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring) 16:893-895
27. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA 2009 Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab 94:3251-3258
28. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y 1996 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803
29. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ 2002 Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87:5662-5667
30. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B 2004 Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15
31. Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT 2009 Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 7:169-179
32. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
33. Van Gaal LF, Mertens IL, De Block CE 2006 Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880
34. Vidal H 2001 Gene expression in visceral and subcutaneous adipose tissues. Ann Med 33:547-555
35. Wahrenberg H, Lonnqvist F, Arner P 1989 Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 84:458-467
36. Arner P 1995 Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 27:435-438
37. Martin ML, Jensen MD 1991 Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88:609-613
38. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM 2006 Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 91:4459-4466
39. Goodpaster BH, Thaete FL, Kelley DE 2000 Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 71:885-892